Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Biotech
STAT+
First Opinion
Insurance alone didn’t guarantee adherence to Ozempic, study finds
Insurance alone didn’t guarantee adherence to Ozempic, study finds
How Tennessee is creating new opportunities for doctors trained…
How Tennessee is creating new opportunities for doctors trained outside the U.S.
Tired of ‘dead end’ approach, herpes patients mobilize to…
Tired of ‘dead end’ approach, herpes patients mobilize to demand government action
Lured by a bigger payday, a medical device maker…
Lured by a bigger payday, a medical device maker sold fake plastic parts. Many were implanted…
Neuralink can now study its brain implant in humans,…
Neuralink can now study its brain implant in humans, but it’s still catching up to its…
Omada tackles obesity drugs, Boston Scientific nixes deal, and…
Omada tackles obesity drugs, Boston Scientific nixes deal, and Microsoft health exec on GPT

Recommended Stories